Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment

Dafina Janevska; Viktorija Chaloska-Ivanova; Vlado Janevski

doi:10.3889/oamjms.2015.111

Authors

Dafina Janevska University Clinic of Gastroenterohepatology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
Viktorija Chaloska-Ivanova University Clinic of Gastroenterohepatology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
Vlado Janevski University Clinic of Abdominal Surgery, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje

DOI:

https://doi.org/10.3889/oamjms.2015.111

Keywords:

hepatocellular carcinoma, risk factors, diagnosis, management, review article

Abstract

Hepatocellular carcinoma (HCC) is the most often primary cancer of the liver and is one if the leading cause of cancer-related death worldwide. The incidence of HCC has geographic distribution with the highest levels in countries with developing economies. Patients with hepatocellular carcinoma have poor prognosis despite the achievements in surgery techniques and other therapeutic procedures and it is a reason why continuous attention should be paid to this issue.

This article provides an overview of this disease based on an extensive review of relevant literature. The article summarizes the current risk factors, diagnosis, staging and the management of HCC.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

El-Serag HB. Hepatocellular Carcinoma. N Engl J Med. 2011;365:1118-27.

http://dx.doi.org/10.1056/NEJMra1001683 DOI: https://doi.org/10.1056/NEJMra1001683

PMid:21992124

Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Annals of Oncology. 1997;8:117-136.

http://dx.doi.org/10.1023/A:1008285123736 DOI: https://doi.org/10.1023/A:1008285123736

PMid:9093719

El-Serag HB, Rudolph KL. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology. 2007;132:2557â€“2576

http://dx.doi.org/10.1053/j.gastro.2007.04.061 DOI: https://doi.org/10.1053/j.gastro.2007.04.061

PMid:17570226

Heidelbaugh JJ., Bruderly M. Cirrhosis and chronic liver failure: Part I. Diagnosis and evaluation. Am Fam Physician. 2006;74:756 â€“762

PMid:16970019

Sanyal AJ, Yoon SK, Lencioni R. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist. 2010;15(suppl 4):14â€“22.

http://dx.doi.org/10.1634/theoncologist.2010-S4-14 DOI: https://doi.org/10.1634/theoncologist.2010-S4-14

PMid:21115577

Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Neoplasms of the Liver, Okuda, K, Ishak, KG (Eds), Springer, Tokyo 1989: p. 3. DOI: https://doi.org/10.1007/978-4-431-68349-0_1

Venook AP, Papandreou C, Furuse J, and LadrÃ³n de Guevara L. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective The Oncologist. 2010;15:5-13. DOI: https://doi.org/10.1634/theoncologist.2010-S4-05

Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74 â€“108.

http://dx.doi.org/10.3322/canjclin.55.2.74 DOI: https://doi.org/10.3322/canjclin.55.2.74

PMid:15761078

Gurtsevitch VE. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc). 2008; 73:504 â€“513.

http://dx.doi.org/10.1134/S0006297908050039 DOI: https://doi.org/10.1134/S0006297908050039

SzabÃ³ E, PÃ¡ska C, Kaposi NovÃ¡k P. et al. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res. 2004; 10:5â€“11.

http://dx.doi.org/10.1007/BF02893401 DOI: https://doi.org/10.1007/BF02893401

PMid:15029254

Alan D, Herbst BA, and Reddy KR. Risk Factors for Hepatocellular Carcinoma. Clinical Liver Disease. 2012;1(6):??. DOI: https://doi.org/10.1002/cld.111

Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, et al. World Gastroenterology Organisation guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis. 2010;19:311â€“317.

http://dx.doi.org/10.1097/mcg.0b013e3181d46ef2 DOI: https://doi.org/10.1097/MCG.0b013e3181d46ef2

Donato F, Tagger A, Gelatti U et al. Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323â€“331.

http://dx.doi.org/10.1093/aje/155.4.323

PMid:11836196

Sheikh MY, Choi J, Qadri I et al. Hepatitis C virus infection: Molecular pathways to metabolic syndrome. Hepatology. 2008;47:2127â€“2133.

http://dx.doi.org/10.1002/hep.22269 DOI: https://doi.org/10.1002/hep.22269

PMid:18446789

Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2009;20:353-357.

http://dx.doi.org/10.1093/annonc/mdn565 DOI: https://doi.org/10.1093/annonc/mdn565

PMid:18723550

Ascha MS, Hanouneh IA, Lopez R, Abu-Rajab Tamini T, Feldstein AF, Zein NN. The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis. Hepatology. 2010;51(6): 1972-8.

http://dx.doi.org/10.1002/hep.23527 DOI: https://doi.org/10.1002/hep.23527

PMid:20209604

El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369-80.

http://dx.doi.org/10.1016/j.cgh.2005.12.007 DOI: https://doi.org/10.1016/j.cgh.2005.12.007

PMid:16527702

Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323-31.

http://dx.doi.org/10.1093/aje/155.4.323 DOI: https://doi.org/10.1093/aje/155.4.323

PMid:11836196

Raphael SW, Yangde Z, and YuXiang C. Hepatocellular Carcinoma: Focus on Different Aspects of Management ISRN Oncology. 2012;Article ID 421673:12 pages. DOI: https://doi.org/10.5402/2012/421673

Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991;350:429.

http://dx.doi.org/10.1038/350429a0 DOI: https://doi.org/10.1038/350429a0

PMid:1672732

Hirohashi S, Blum HE, Ishak KG, Deugnier Y, Kojiro M, Laurent Puig P, Wanless IR, Fischer HP, Theise ND, Sakamoto M, Tsukuma H. Hepatocellular carcinoma in World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System IARCPress Lyon, 2000

El-Serag HB, Marrero JA, Rudolph L, and Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134(6):1752â€“1763.

http://dx.doi.org/10.1053/j.gastro.2008.02.090 DOI: https://doi.org/10.1053/j.gastro.2008.02.090

PMid:18471552

Somi MH. Hepatocellular Carcinoma. Hepatitis Monthly. 2005; 5(3): 65-76

Ryder SD. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003; 52(suppl 3):iii1â€“iii8.

http://dx.doi.org/10.1136/gut.52.suppl_3.iii1 DOI: https://doi.org/10.1136/gut.52.suppl_3.iii1

PMid:12692148 PMCid:PMC1867754

Bolog N, Andreisek G, Oancea I, and Mangrau A. CT and MR imaging of hepatocellular carcinoma. Journal of Gastrointestinal and Liver Diseases. 2011;20(2):181â€“189.

PMid:21725516

Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther. 2010; 15;31(4):461-76. DOI: https://doi.org/10.1111/j.1365-2036.2009.04200.x

Marrero JA, Hussain HK, Nghiem HV, et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl. 2005;11: 281â€“9.

http://dx.doi.org/10.1002/lt.20357 DOI: https://doi.org/10.1002/lt.20357

PMid:15719410

Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36.

http://dx.doi.org/10.1002/hep.20933 DOI: https://doi.org/10.1002/hep.20933

PMid:16250051

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies. Bertino G, Demma S, Ardiri A, Proiti M, Gruttadauria S, Toro A, Malaguarnera G, Bertino N, Malaguarnera M, Malaguarnera M, and Di Carlo I. BioMed Research International. 2014;Article ID 203693:15 pages. DOI: https://doi.org/10.1155/2014/203693

Pons F, Varela M, and Llovet MJ. Staging systems in hepatocellular carcinoma. HPB (Oxford). 2005; 7(1):35-41.

http://dx.doi.org/10.1080/13651820410024058 DOI: https://doi.org/10.1080/13651820410024058

PMid:18333159 PMCid:PMC2023920

European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56: 908-943.

http://dx.doi.org/10.1016/j.jhep.2011.12.001 DOI: https://doi.org/10.1016/j.jhep.2011.12.001

PMid:22424438

Bruix J, Shereman M. Management of hepatocellular carcinoma: An update. Hepatology. 2011;53(3):1020â€“1022.

http://dx.doi.org/10.1002/hep.24199 DOI: https://doi.org/10.1002/hep.24199

PMid:21374666 PMCid:PMC3084991

Raza A, Sood GK. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(15):4115-4127.

http://dx.doi.org/10.3748/wjg.v20.i15.4115 DOI: https://doi.org/10.3748/wjg.v20.i15.4115

PMid:24764650 PMCid:PMC3989948

Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89.

http://dx.doi.org/10.1002/hep.21933 DOI: https://doi.org/10.1002/hep.21933

PMid:18008357

Wang P, Sheng L, Mang G, Wang H, Huang X, Yan X, Yang X and Pei R. Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma. Mol Clin Oncol. 2014; 2(2): 203â€“206. DOI: https://doi.org/10.3892/mco.2014.239

PMid:24649333 PMCid:PMC3917780

Greten T F , Papendorf F, Bleck J S , Kirchhoff T , Wohlberedt T, Kubicka S , Klempnauer J , Galanskiand M, Manns M P. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. BJC. 2005;92:1862â€“1868.

http://dx.doi.org/10.1038/sj.bjc.6602590 DOI: https://doi.org/10.1038/sj.bjc.6602590

PMid:15870713 PMCid:PMC2361778

Hirohashi S, Blum HE, Ishak KG, Deugnier Y, Kojiro M, Laurent Puig P, Wanless IR, Fischer HP, Theise ND, Sakamoto M, Tsukuma H. Hepatocellular carcinoma in World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System IARC Press:Lyon, 2000.